Telix Pharmaceuticals | Des Atouts



Assets Changement Date
Cochlear AUD 2.79B 41M 2024-12
CSL USD 38.45B 425M 2024-12
Integral Diagnostics AUD 744.28M 1.52M 2024-06
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 65.33M 6.17M 2024-12
Mesoblast 669.15M 1.13M 2024-06
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Pacific Edge NZD 50.85M 14.6M 2024-09
Paradigm Biopharmaceuticals AUD 35.36M 7.97M 2024-12
Polynovo AUD 108.72M 11.51M 2024-06
PYC Therapeutics AUD 68.23M 23.01M 2024-12
Ramsay Health Care AUD 20.66B 237M 2024-12
ResMed USD 7.14B 81.08M 2024-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12



Telix Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jun 2025.